Myomo (MYO) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2025)
Powered by 
Analysis
Myomo (MYO) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 12.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 11.36% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 6.67% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 6.92% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 19.21% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 6.67% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 2.86% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 8.23% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 5.69% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | 66.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 66.38% |
| Sep 30, 2025 | 561.79% |
| Jun 30, 2025 | 905.45% |
| Mar 31, 2025 | 794.66% |
| Dec 31, 2024 | 656.57% |
| Sep 30, 2024 | 226.32% |
| Jun 30, 2024 | 88.20% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | -9.52% |
| Sep 30, 2023 | -28.31% |
| Jun 30, 2023 | -45.74% |
| Mar 31, 2023 | -31.77% |
| Dec 31, 2022 | -29.43% |
| Sep 30, 2022 | -20.57% |
| Jun 30, 2022 | -11.53% |
| Mar 31, 2022 | 32.93% |
| Dec 31, 2021 | 189.71% |
| Sep 30, 2021 | 186.12% |
| Jun 30, 2021 | 191.44% |
| Mar 31, 2021 | 51.07% |